Market research
18H.F PreveCeutical Medical Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 14M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.23
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- CA74141E1043
- Market cap
- 14M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.23
About
About PreveCeutical Medical Inc
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; and BSV Peptide Program that targets cancer progression. The company is headquartered in West Vancouver, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 18H.F discussion.
5 years, 4 months ago
PreveCeutical Medical Inc is currently in a long term downtrend where the price is trading 45.6% below its 200 day moving average.
From a valuation standpoint, the stock is 50.2% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 1973.4.
PreveCeutical Medical Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 173.8% to $451K since the same quarter in the previous year.
Finally, its free cash flow grew by 1013.7% to $499K since the same quarter in the previous year.
Based on the above factors, PreveCeutical Medical Inc gets an overall score of 2/5.